申请人:Kyorin Pharmaceutical Co., Ltd.
公开号:US07759326B2
公开(公告)日:2010-07-20
Aminophosphonic acid derivatives (e.g., 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonate monoester) are represented by the following general formula (1):
and act as effective S1P receptor modulators while posing less side effects.
氨基膦酸衍生物(例如,2-氨基-5-[4-(3-苄氧基苯基硫基)-2-氯苯基]-2-甲基戊基膦酸单酯)由以下一般式(1)表示,并作为有效的S1P受体调节剂,同时副作用较小。